Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,778 public trials 699 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Prospective Study of the Prognostic Value of New Markers in Adults With ALK-positive Large Anaplastic Lymphoma

NCT03603847

Conditions
Anaplastic Large Cell Lymphoma, ALK-Positive, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • CHU Amiens - Hôpital Sud Amiens, France
  • CHU d'Estaing Clermont-Ferrand, France
  • APHP - Hopital Henri Mondor Créteil, France
  • CHU Grenoble Grenoble, France
View all 15 locations
View Trial Details
Completed

Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma

NCT01336933

Conditions
Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hemic and Lymphatic Diseases, +15 more
Locations
  • Mayo Clinic, Arizona Scottsdale, Arizona, United States
  • Stanford University Stanford, California, United States
  • Emory University School Of Medicine Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details
Completed

Mogamulizumab and Pembrolizumab in Treating Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma

NCT03309878

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +14 more
Locations
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
View Trial Details
Completed

Phase 1&2 Study to Evaluate the Safety & Efficacy of Inhaled IBIO123 in Severe COVID-19 Illness

NCT05303376

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +23 more
Locations
  • JOHESE UNITAS Hospital Lyttelton, Centurion, South Africa
  • JOHESE ZAH Hospital Pretoria, Gauteng, South Africa
  • Central City Clinical Hospital of Ivano-Frankivsk City Council Ivano-Frankivsk, Ivano-Frankivsk Oblast, Ukraine
  • City Clinical Hospital #1 of Ivano-Frankivsk City Council Ivano-Frankivsk, Ivano-Frankivsk Oblast, Ukraine
View Trial Details
Completed

Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

NCT00078949

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +19 more
Locations
  • Rush-Presbyterian-St. Luke's Medical Centre Chicago, Illinois, United States
  • Indiana University Medical Center Indianapolis, Indiana, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • University of Cincinnati, Barrett Cancer Centre Cincinnati, Ohio, United States
View all 27 locations
View Trial Details
Completed

CC486-CHOP in Patients With Previously Untreated Peripheral T-cell Lymphoma

NCT03542266

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Weill Cornell Medicine New York, United States
View Trial Details

Related conditions